PER-017-98已完成未知
ORAL LINEZOLID IN THE TREATMENT OF EXTRAHOSPITAL PNEUMONIA IN AMBULATORY PATIENTS
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,0 个研究点目标入组 0 人开始时间: 1998年7月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
2 期
To observe if administration of drug namely linezolid along with standard four drug regimen in intensive(initial) phase of Tubercular meningitis will help reduce death and disability among patients when compared to standard four drugAntitubercular drug therapy alone.CTRI/2019/06/019501Aiims
进行中（未招募）
1 期
andiolol for improved outcome in cardiac arrestEUCTR2020-003661-19-ATMedical University of Vienna32
已完成
不适用
Optimal individual administration of linezolid and tedizolid using saliva concentrations to avoid blood sampling A single oral and intravenous dose of linezolid and tedizolid in healthy adult males (investigator-initiated clinical study)Healthy adult malesJPRN-UMIN000046556niversity of Toyama12
进行中（未招募）
不适用
Investigation of the blood levels of selected antibiotics in critically ill patients undergoing dialysisSepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and may result in either underdosing, causing treatment failure and antibiotic resistance, or overdosing resulting in drug toxicity. The aim of this study is to collect pharmacokinetic data for evaluating underdosing or overdosing of linezolid and meropenem in patients receiving renal replacement therapy.EUCTR2013-000899-16-DEDepartment of Pharmacy Unversitätsmedizin Mainz
已完成
4 期
Linezolid for Treatment of Nontuberculous Mycobacterial DiseasesNon-tuberculous Mycobacterial InfectionsNCT03220074Mahidol University40